NashBio Revenue
Biotechnology Research • 
Nashville, Tennessee, United States • 21-50 Employees
NashBio revenue & valuation
| Annual revenue | $2,652,205 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $8,500,000 |
| Total funding | No funding |
Key Contacts at NashBio
Erik Serrao
Business Director
Leeland Ekstrom
Ceo & Co-Founder
Seth Belcher
Business Director
Daniel. A. Gutierrez
Business Director Central Europe
Keith D. Coon
Business Director
Jamie Wenke
Director, Scientific Project And Program Management
Curt Allen
Vp Of Sales
Amber Watson
Associate Medical Director, Head Of Medical Affairs
Jennifer Cotter
Associate Director, Clinical And Scientific Partnerships
Company overview
| Headquarters | 2525 West End Ave, Suite 930, Nashville, TN 37203, US |
| Phone number | +16152085462 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Big Data, Pharmaceuticals, Emrs, Clinical Records, Dna Samples |
| Founded | 2018 |
| Employees | 21-50 |
| Socials |
NashBio Email Formats
NashBio uses 5 email formats. The most common is {first initial} (e.g., j@nashbio.com), used 29.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@nashbio.com | 55.5% |
{first name} | john@nashvillebiosciences.com | 11.1% |
{first name}.{last name} | john.doe@nashbio.com | 11.1% |
{first initial}.{last name} | j.doe@nashbio.com | 7.4% |
About NashBio
At NashBio, we make complex healthcare data easy to use. From idea to execution, we leverage real-world clinical, genomic and imaging data to advance the discovery and development of new therapeutics and diagnostics. A for-profit subsidiary of Vanderbilt University Medical Center, NashBio was launched in 2018 with a mission to harness extensive real-world genomics and other multi-modal datasets, along with powerful bioinformatics tools, to build and deliver a wide range of data products and services that support life science R&D. Our company works with clients in pharma, biotech, diagnostics, medical devices and other life sciences domains to support their most critical R&D use cases. We believe smarter data ultimately enables better outcomes for our clients. Leveraging Vanderbilt University Innovation, NashBio’s hallmarks are deep, high quality, longitudinal datasets that are demographically diverse and clinically relevant, integrated and curated for ease of customer use. In 2023, NashBio launched the Alliance for Genomic Discovery (AGD), in collaboration with Illumina and eight leading pharmaceutical companies, to build one the world’s largest collections of whole genome sequence data linked to de-identified medical records for drug discovery & development. For more information about NashBio, please visit our website.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
NashBio has 15 employees across 8 departments.
Departments
Number of employees
Funding Data
NashBio has never raised funding before.
NashBio Tech Stack
Discover the technologies and tools that power NashBio's digital infrastructure, from frameworks to analytics platforms.
Security
WordPress plugins
JavaScript libraries
JavaScript libraries
UI frameworks
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Analytics
WordPress plugins
JavaScript libraries
New Zealand
Australia
Malta
Denmark
United Kingdom
Frequently asked questions
4.8
40,000 users
